À¯ÀüÀÚ ÆíÁý ½ÃÀå ºÐ¼®°ú ¿¹Ãø(-2033³â) : À¯Çü, Á¦Ç°, ¼­ºñ½º, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ÄÄÆ÷³ÍÆ®, ÇÁ·Î¼¼½º, ¸ðµå, ½ºÅ×ÀÌÁöº°
Genome Editing Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Component, Process, Mode, Stage
»óǰÄÚµå : 1598964
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 386 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,582,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 7,968,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,354,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

À¯ÀüÀÚ ÆíÁý ½ÃÀå ±Ô¸ð´Â 2023³â 101¾ï ´Þ·¯¿¡¼­ ¾à 13.1%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2033³â¿¡´Â 355¾ï ´Þ·¯·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯ÀüÀÚ ÆíÁý ½ÃÀå¿¡´Â ¿øÇÏ´Â ÇüÁúÀ̳ª °á°ú¸¦ ¾ò±â À§ÇØ À¯Àü ¹°ÁúÀ» º¯Çü½ÃŰ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÏ´Â ±â¼ú°ú ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡´Â CRISPR, TALEN, ZFN ±â¼úÀÌ Æ÷ÇԵǸç, ÀÇ·á, ³ó¾÷, »ý¸í°øÇÐ ºÐ¾ß¿¡¼­ÀÇ ÀÀ¿ëµµ Æ÷ÇԵ˴ϴÙ. Áúº´ Ä¡·á, ÀÛ¹° °³·®, °úÇÐ ¿¬±¸ Áøº¸¸¦ Áö¿øÇϰí À¯Àü°øÇÐ ¹× ¸ÂÃãÇü ÀÇ·áÀÇ Çõ½ÅÀ» ÃËÁøÇÕ´Ï´Ù.

À¯ÀüÀÚ ÆíÁý ½ÃÀåÀº CRISPR ±â¼úÀÇ ¹ßÀü°ú ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ ÀÀ¿ë Áõ°¡·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Ä¡·áÁ¦ ºÎ¹®Àº ƯÈ÷ À¯ÀüÀÚ Ä¡·á¿Í Àç»ý ÀÇÇп¡¼­ Áö±Ý±îÁö Ä¡·áÇÒ ¼ö ¾ø¾ú´ø Áúº´À» Ä¡·áÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ¸·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ³ó¾÷ »ý¸í°øÇÐÀº ÀÛ¹° ¼öÈ®·® Áõ°¡¿Í ÇØÃæ ¹× ±âÈÄ º¯È­¿¡ ´ëÇÑ ÀúÇ×¼º Çâ»ó¿¡ ÈûÀÔ¾î µÎ ¹øÂ°·Î ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÌ´Â ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î º¸¸é ºÏ¹Ì´Â °­·ÂÇÑ ¿¬±¸ ÀÎÇÁ¶ó, ´ë±Ô¸ð ÀÚ±Ý Á¶´Þ ¹× Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©ÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ´Â ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº Àü·«Àû °øµ¿¿¬±¸¿Í Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ÁýÁß¿¡ ÈûÀÔ¾î ºÏ¹Ì¸¦ ±Ù¼ÒÇÑ Â÷ÀÌ·Î Ãß°ÝÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹°ú µ¶ÀÏÀº Çõ½Å°ú źźÇÑ »ý¸í°øÇÐ »ýŰ踦 Áß½ÃÇÏ´Â ¹Ì±¹°ú µ¶ÀÏÀÌ ÁÖ¿ä ±â¿© ±¹°¡·Î ²ÅÈü´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ³ó¾÷ ¹× ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ À¯ÀüÀÚ ÆíÁý ±â¼ú äÅà Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ À¯ÀüÀÚ ÆíÁý ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ ºÐ¼®, ¹ý±ÔÁ¦ ȯ°æ, »ç·Ê ¿¬±¸, ½ÃÀå ±Ô¸ð ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå À¯ÀüÀÚ ÆíÁý : ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®

Á¦4Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå Àü¸Á

Á¦5Àå À¯ÀüÀÚ ÆíÁý : ½ÃÀå Àü·«

Á¦6Àå À¯ÀüÀÚ ÆíÁý : ½ÃÀå ±Ô¸ð

Á¦7Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : À¯Çüº°

Á¦8Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : Á¦Ç°º°

Á¦9Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ¼­ºñ½ºº°

Á¦10Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ±â¼úº°

Á¦11Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ¿ëµµº°

Á¦12Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦13Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦14Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ÇÁ·Î¼¼½ºº°

Á¦15Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ¸ðµåº°

Á¦16Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ½ºÅ×ÀÌÁöº°

Á¦17Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : Áö¿ªº°

Á¦18Àå °æÀï ±¸µµ

Á¦19Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The genome editing market is anticipated to expand from $10.1 billion in 2023 to $35.5 billion by 2033, reflecting a CAGR of approximately 13.1%.

The genome editing market encompasses the technologies and services aimed at modifying genetic material to achieve desired traits or outcomes. This market includes CRISPR, TALENs, and ZFNs technologies, along with applications in healthcare, agriculture, and biotechnology. It supports advancements in disease treatment, crop improvement, and scientific research, driving innovation in genetic engineering and personalized medicine.

The genome editing market is experiencing robust growth, driven by advancements in CRISPR technology and increasing applications in healthcare. The therapeutics segment leads the market, particularly in gene therapy and regenerative medicine, due to its potential to treat previously incurable diseases. Agricultural biotechnology emerges as the second-highest performing sub-segment, fueled by the need for improved crop yields and resistance to pests and climate change.

Regionally, North America dominates the market, benefiting from strong research infrastructure, significant funding, and supportive regulatory frameworks. Europe follows closely, propelled by strategic collaborations and a focus on precision medicine. Within these regions, the United States and Germany are key contributors, given their emphasis on innovation and robust biotech ecosystems. The Asia-Pacific region is poised for rapid growth, driven by rising investments in research and development and increasing adoption of genome editing technologies in agriculture and healthcare. This growth trajectory underscores the lucrative opportunities for stakeholders across the genome editing landscape.

Key Companies

Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Beam Therapeutics, Precision Bio Sciences, Sangamo Therapeutics, Cellectis, Horizon Discovery, Caribou Biosciences, Graphite Bio, Poseida Therapeutics, Tessera Therapeutics, Prime Medicine, Mammoth Biosciences, Synthego, Inscripta, Locus Biosciences, e Genesis, Pairwise Plants, Apexigen, Scribe Therapeutics, Verve Therapeutics, Rejuvenate Bio, Metagenomi, Chroma Medicine

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1. Genome Editing Market Overview

2. Executive Summary

3. Premium Insights on the Market

4. Genome Editing Market Outlook

5. Genome Editing Market Strategy

6. Genome Editing Market Size

7. Genome Editing Market, by Type

8. Genome Editing Market, by Product

9. Genome Editing Market, by Services

10. Genome Editing Market, by Technology

11. Genome Editing Market, by Application

12. Genome Editing Market, by End User

13. Genome Editing Market, by Component

14. Genome Editing Market, by Process

15. Genome Editing Market, by Mode

16. Genome Editing Market, by Stage

17. Genome Editing Market, by Region

18. Competitive Landscape

19. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â